Medical/Pharmaceuticals
Caliway Biopharmaceuticals Announces Initiation of Subject Recruitment in CBL-0204 Phase 2b Study Evaluating the Efficacy of CBL-514 in Abdominal Subcutaneous Fat Reduction
- Caliway has initiated the subject recruitment in CBL-0204 Phase 2b study. - The study is expected to be completed in Q2 2024, and the topline results are anticipated in Q3 2024. TAIPEI, May 31, 2023 /PRNewswire/ -- Caliway Biopharmaceuticals, a biopharmaceutical company focusing on breakthroug...
2023-05-31 20:15
4734
THINK Surgical's TMINI Miniature Robotic System developed with Sagentia Innovation gains FDA 510(k) clearance
CAMBRIDGE, England, May 31, 2023 /PRNewswire/ -- THINK Surgical, Inc. recently
announced that its TMINI™ Miniature Robotic System has received 510(k)
clearance from the U.S. Food and Drug Administration (FDA).
2023-05-31 15:00
4383
SNIPR Biome reports positive clinical interim results for groundbreaking, first-in-human, CRISPR-based microbial gene therapy
* SNIPR001 demonstrates proof of principle in reducing E. coli levels in the human gastrointestinal tract * SNIPR001 is a novel CRISPR-Cas therapeutic, selectively targeting antibiotic-resistant E. coli which can cause life-threatening infections in vulnerable hematological cancer patients ...
2023-05-31 14:58
2846
Cambrex Celebrates Grand Opening of New Q1 Scientific Facility in Belgium and Secures First Stability Storage Commercial Agreement
EAST RUTHERFORD, N.J, May 31, 2023 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, yesterday celebrated the grand opening of its new Q1 Scientific...
2023-05-31 14:30
3235
AffaMed Therapeutics Announces Completion of Patient Enrollment in the Real-World Study in China Evaluating the Safety and Efficacy of DEXTENZA® in Cataract Surgery Patients
SHANGHAI, May 31, 2023 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global biotechnology company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmological, neurological and psychiat...
2023-05-31 11:39
3294
Lynk Pharmaceuticals Completes 200 Million RMB Series C1 Financing to Accelerate Clinical Development of Core Products
HANGZHOU, China, May 31, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, today announced the successful completion of aRMB 200 million Series C1 financing round. There was joint participation by China G...
2023-05-31 08:25
6683
Excellent 12-Month Results from SELUTION SFA Trial Presented at JET
GENEVA, May 31, 2023 /PRNewswire/ -- 12-month results from the SELUTION SFA trial have been presented at the Japan Endovascular Treatment (JET) Conference inTokyo. The objective of this study was to assess the safety and efficacy of SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, fo...
2023-05-31 08:00
3650
Brain-computer interface to control digital devices using thoughts: The European Patent Office has announced that Australian researchers have been selected as finalists for the European Inventor Award 2023
MUNICH, May 31, 2023 /PRNewswire/ -- Nearly one in six of the world's population lives with neurological disorders such as Alzheimer's, Parkinson's disease, stroke, epilepsy, or migraines and brain injuries, according to the United Nations. In an effort to improve the quality of life for those af...
2023-05-31 05:00
2941
LZ901, A Recombinant Herpes Zoster Vaccine And The Core Product Of Luzhu Biotechnology, Completed Phase II Clinical Trail In Q2 2023
World's First Herpes Zoster Vaccine With A Tetrameric Molecular Structure BEIJING, May 30, 2023 /PRNewswire/ -- Beijing Luzhu Biotechnology Co., Ltd. ("Luzhu Biotechnology" or the "Company", together with its subsidiaries, the "Group", stock code: 02480.HK), a leading vaccine and antibody drug de...
2023-05-30 22:07
4305
Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand
MUMBAI, India and SIENA, Italy, May 30, 2023 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO), (Bloomberg: SUNP IN), (NSE: SUNPHARMA), (BSE: 524715) (together with its subsidiaries and/or associated companies, "Sun Pharma") and Philogen S.p.A (BIT: PHIL) today announced tha...
2023-05-30 22:05
3691
Fullerton Health Officially Opens its Flagship Health Screening Centre at Novena
This is one of the largest and most comprehensive health screening & preventative health facilities inSingapore SINGAPORE, May 30, 2023 /PRNewswire/ -- Fullerton Health Group's (FHG) newest and largest Health Screening Centre was officially launched by Health Minister Ong Ye Kung at an official o...
2023-05-30 15:00
5460
BMC Corporate Launches New Products and Strategies at Latest Exhibitions
BEIJING, May 30, 2023 /PRNewswire/ -- BMC participated in two comprehensive exhibitions inMay 2023 - CMEF and Hospitalar. At these events, BMC showcased not only its newest products and solutions, but also its business Strategies. Founded in 2001, BMC's mission is to partner with families worldwi...
2023-05-30 12:43
3958
VISTA Eye Specialist Shines At The Natural Health & Readers' Choice Awards 2022
PETALING JAYA, Malaysia, May 30, 2023 /PRNewswire/ -- VISTA Eye Specialist, one of the leading eye specialists inMalaysia with 14 locations throughout the nation has once again emerged victorious at the Natural Health Awards and Readers' Choice Awards 2022 by winning the Best LASIK Eye Surgery Ce...
2023-05-30 10:16
3468
Guardant Health Receives Regulatory Approval from Singapore's Health Sciences Authority for Guardant360® CDx blood test for patients with advanced solid cancers
* Guardant360® CDx is a comprehensive genomic profiling blood test that provides critical information to help inform personalized treatment decisions for patients with advanced solid cancers * The liquid biopsy test is also approved as a companion diagnostic for TAGRISSO® (osimertinib) in ...
2023-05-30 09:00
4282
Haleon's Panadol Klinik Cekatan extends reach to people with limited mobility and healthcare access in areas affected by natural disasters
* The extended program aims provide 10,000 free consultations across 16 villages in Cugenang district affected by 2022 earthquake * The eight-week mobile clinic services program to deploy pilot Pain Phone unit to facilitate telehealth consultation JAKARTA, Indonesia, May 29, 2023 /PRNewswir...
2023-05-29 21:51
6791
Concept Medical's fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)
TAMPA, Fla., May 29, 2023 /PRNewswire/ -- The US FDA, on the 24th of May 2023,
granted an Investigational Device Exemption (IDE) approval forConcept Medical
Inc's
2023-05-29 19:40
4725
Hummingbird Bioscience Announces HMBD-002 Trials in Progress Poster at ASCO Annual Meeting 2023
* HMBD-002, a non-depleting, high-affinity anti-VISTA antibody, possesses key design features enabling robust anti-tumor activity in preclinical models, positioning it as a potentially important new therapy for VISTA-expressing cancers including triple-negative breast cancer and non-small cell ...
2023-05-29 18:30
3710
Kosme Aesthetics Celebrates the Opening of its Modern Aesthetic Salon at Plaza Singapura, Orchard Road, Offering a Comprehensive Range of Signature Treatments
SINGAPORE, May 29, 2023 /PRNewswire/ -- Kosme Aesthetics, a renowned provider of state-of-the-art aesthetic treatments inSingapore, is excited to announce the opening of its new salon at Plaza Singapura, #04-08D, Orchard Road. The contemporary facility showcases the brand's dedication to offering...
2023-05-29 11:10
2701
APPLICATION OF HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT: EXPERIENCE FROM THE WORLD AND SITUATION IN VIETNAM
HO CHI MINH CITY, Vietnam, May 29, 2023 /PRNewswire/ -- In the limited medical sources circumstance, the technology evaluation will help policymakers choose and establish the most appropriate health technology coordinating with conditions and actual occurrences, thereby ensuring the best medical ...
2023-05-29 11:00
3046
Menarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Metastatic Breast Cancer at ASCO 2023
* ORSERDU (elacestrant) was approved by the FDA in January 2023 for estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer withESR1-mutations (ESR1-mut) that are found in up to 40% of tumors * In patients whose tumors har...
2023-05-26 20:37
4357
Week's Top Stories
Most Reposted
Visa returns as title sponsor for 2026 MAMA AWARDS; Visa Presale registration begins 13 October
[Picked up by 310 media titles]
2026-10-13 10:00
Agoda and Emerging Travel Group Enter Strategic Partnership
[Picked up by 292 media titles]
2026-10-15 16:00Food & Hospitality Asia 2027 Redefining Excellence: The Premier Platform for Food & Beverage and Hospitality Innovation
[Picked up by 282 media titles]
2026-10-15 10:00Leading Asian DMC Discova to Attend ITB Asia 2026
[Picked up by 280 media titles]
2026-10-15 12:59
DayOne Upsizes Malaysia Financing to US$7.2 Billion; Total Billings Surpass 1GW and Bookings Reach 2.3GW
[Picked up by 270 media titles]
2026-10-14 18:01Most Read
Sonilo Raises $11M to Build the AI-Native Audio Stack for Video
2026-10-15 00:00
21026
Visa returns as title sponsor for 2026 MAMA AWARDS; Visa Presale registration begins 13 October
2026-10-13 10:00
19494
Agoda and Emerging Travel Group Enter Strategic Partnership
2026-10-15 16:00
9545